PROFILBARU.COM

Moncef Slaoui
Moncef Slaoui
	Slaoui dengan CEO GlaxoSmithKline Emma Walmsley (Desember 2016)
Lahir	Moncef Mohamed Slaoui; 22 Juli 1959 (umur 65); Agadir, Maroko
Kebangsaan	Maroko
Kewarganegaraan	Belgia; Amerika Serikat;
Pendidikan	Université libre de Bruxelles (BS, MS, PhD); International Institute for Management Development (MBA)
Dikenal atas	Operasi Warp Speed
Anak	3
	Karier ilmiah
Bidang	Mikrobiologi; Imunologi;
Institusi	Universitas Mons; SmithKline-RIT; GlaxoSmithKline; Medicxi;
Disertasi	Etude de la diversité et de la sélection des répertoires idiotypiques dans le système immunitaire (1983)
Pembimbing doktoral	Jacques Urbain

Moncef Mohamed Slaoui^[1] (lahir 22 Juli 1959) adalah seorang peneliti Belgia-Amerika kelahiran Maroko dan mantan kepala departemen vaksin GlaxoSmithKline.^[2] Ia bekerja di perusahaan tersebut selama tiga puluh tahun, pensiun pada 2017. Pada 15 Mei 2020, Presiden Donald Trump mengumumkan bahwa Slaoui bakal mengurusi pengembangan vaksin pemerintah Amerika Serikat yang dipakai untuk mengobati penyakit koronavirus dalam Operasi Warp Speed.^[3]

Karya pilihan dan publikasi

Karya

Scholia memiliki profil author tentang Moncef Slaoui.

Slaoui, Mohamed Monsif (1983). Etude de la diversité et de la sélection des répertoires idiotypiques dans le système immunitaire (dalam bahasa Prancis). Bruxelles: Université libre de Bruxelles, Faculté des sciences. identifier: ulbcat.ulb.ac.be:537608
Rosenthal, Susan L.; Stanberry, Lawrence R.; Biro, Frank M.; Slaoui, Moncef; Francotte, Myriam; Koutsoukos, Marguerite; Hayes, Marianne; Bernstein, David I. (February 1997). "Seroprevalence of Herpes Simplex Virus Types 1 and 2 and Cytomegalovirus in Adolescents". Clinical Infectious Diseases. 24 (2): 135–139. doi:10.1093/clinids/24.2.135 . Templat:Wikidata+icon
Keadle, Tammie L.; Laycock, Keith A.; Miller, Judith Kelvin; Hook, Kelly K.; Fenoglio, E. D.; Francotte, Myriam; Slaoui, Moncef; Stuart, P. Michael; Pepose, Jay S. (August 1997). "Efficacy of a Recombinant Glycoprotein D Subunit Vaccine on the Development of Primary and Recurrent Ocular Infection with Herpes Simplex Virus Type 1 in Mice". The Journal of Infectious Diseases. 176 (2): 331–338. doi:10.1086/514049 . PMID 9237697. Templat:Wikidata+icon
Stanberry, Lawrence R.; Spruance, Spotswood L.; Cunningham, Anthony L.; Bernstein, David I.; Mindel, Adrian; Sacks, Stephen; Tyring, Stephen; Aoki, Fred Y.; Slaoui, Moncef; Denis, Martine; Vandepapeliere, Pierre; Dubin, Gary (November 21, 2002). "Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes". The New England Journal of Medicine. 347 (21): 1652–1661. doi:10.1056/NEJMOA011915 . PMID 12444179. Templat:Wikidata+icon
Bourne, Nigel; Bravo, Fernando J.; Francotte, Myriam; Bernstein, David I.; Myers, Martin G.; Slaoui, Moncef; Stanberry, Lawrence R. (February 15, 2003). "Herpes Simplex Virus (HSV) Type 2 Glycoprotein D Subunit Vaccines and Protection against Genital HSV‐1 or HSV‐2 Disease in Guinea Pigs". The Journal of Infectious Diseases. 187 (4): 542–549. doi:10.1086/374002 . PMID 12599070. Templat:Wikidata+icon
Slaoui, Moncef (April 23, 2010). "The rise and fall of rosiglitazone: reply". European Heart Journal. 31 (10): 1282–1284. doi:10.1093/EURHEARTJ/EHQ118 . PMID 20499440. Templat:Wikidata+icon
Famm, Kristoffer; Litt, Brian; Tracey, Kevin J.; Boyden, Edward S.; Slaoui, Moncef (April 10, 2013). "A jump-start for electroceuticals". Nature. 496 (7444): 159–161. doi:10.1038/496159A . PMC 4179459 . PMID 23579662. Templat:Wikidata+icon
Uguen, David; Lönngren, Thomas; Le Cam, Yann; Garner, Sarah; Voisin, Emmanuelle; Incerti, Carlo; Dunoyer, Marc; Slaoui, Moncef (2014). "Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches: features and perspectives". Orphanet Journal of Rare Diseases. 9 (1): 20. doi:10.1186/1750-1172-9-20 . PMC 3923002 . PMID 24513034. Templat:Wikidata+icon

Publikasi

Slaoui, Moncef (July 1, 2013). "It's Time to Further Incentivize Medical Innovation". Huffington Post.

Referensi

^ US Expired 8597656B2, Cabezon, Teresa Silva; Slaoui, Moncef Mohamed & Cohen, Joseph et al., "Process for the production of immunogenic compositions", diterbitkan tanggal March 12, 2013, dikeluarkan tanggal March 12, 2013, diberikan kepada GlaxoSmithKline Biologicals SA
^ Mullard, Asher (July 1, 2015). "Moncef Slaoui". Nature Reviews Drug Discovery. 14 (7): 452–453. doi:10.1038/NRD4669 . PMID 26129795. Templat:Wikidata+icon
^ Sanger, David E.; Haberman, Maggie; Weiland, Noah (May 15, 2020). "Trump Vows Vaccine by End of Year, and Mobilizes Military to Help". The New York Times.